Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, ...
Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer progression and patient health. Stage 1 focuses on tumor removal, Stage 2 ...
It is from these cells, which express a gene called Krt5 that helps to build the structure of cells, that lung squamous cell carcinoma (LUSC) eventually develops. The research team say the findings ...
Image of a lung lobe from a carcinogen-exposed mouse. Cells expressing the basal cell marker KRT5 have been fluorescently labelled and can be seen spreading throughout the bronchial tree The ‘cell of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback